LDC takes majority stake in Agentis Health Group
Context
Founder Laurence Sprey sold Ashtons Hospital Pharmacy Services, the Brighton-based medicines management provider he had established, to LDC in a management buyout completed in March 2020. LDC director Christian Bruning and investment director Joe Tager led the investment and joined the board, while the existing management team of chief executive Yachna Tak, chief pharmacist Martin England and finance director Keith Hersee stayed on with LDC's backing. Silicon Valley Bank provided the banking facilities. At the time of the deal, Ashtons (renamed Agentis Health Group after the deal) employed 90 people and generated revenue of £5–25M, after growing by 70 per cent over the previous three years. LDC's investment was to fund organic growth, the further development of the company's software services and the expansion of its pharmaceutical warehousing and distribution network. EMC Corporate Finance acted as lead advisor to Ashtons and its management, with DMH Stallard advising the company on legal matters, Osborne Clarke advising management, and PwC on tax. LDC was advised by Clearwater, BDO on financial and tax matters, DLA on legal matters, Candesic on commercial due diligence, Intechnica on IT and Matrix on insurance.
-> Deep-dive in Healthcare & Pharma market trends
Target
Launched in 2025 and based in Brighton, Agentis Health Group provides pharmacy services and digital tools for managing long-term conditions in the United Kingdom. Its work is organised into three areas, Agentis Healthcare, Agentis Pharmacy and Agentis Labs, and rests on the Living With platform, which combines a clinical dashboard with a patient app to deliver condition-specific therapy and remote support for patients with heart failure, lung conditions such as asthma and COPD, or diabetes. Clinicians use it to monitor symptoms and review medication when a patient's condition worsens. Its customers are NHS commissioners, integrated care boards, NHS trusts, community providers, primary care networks and GP practices.
Ent. Value
[members only]
Equity Value
[members only]
Multiples
EV / Revenue
[members only]
EV / EBITDA
[members only]
EV / EBIT
[members only]
Historical Financials (GBP)
Other operations with Agentis Health Group
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 08/2026 | AGENTIS HEALTH GROUP | CLINICAL PHARMACIST SOLUTIONS | UNITED KINGDOM | Healthcare Services |
Other operations with LDC
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 06/2026 | LDC | UBDS GROUP | UNITED KINGDOM | Consulting & Integration |
| 10/2022 | LDC | ACORA | UNITED KINGDOM | MSP (Managed Services) |
Similar deals in Healthcare Services
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 09/2023 | CERBA HEALTHCARE | CIRION BIOPHARMA RESEARCH | CANADA | CRO / Clinical Trials |
| 09/2023 | PERMIRA | ERGOMED | UNITED KINGDOM | CRO / Clinical Trials |
| 06/2023 | SUPERNOVA INVEST / HEAL CAPITAL | GLEAMER | FRANCE | Health Tech |
| 06/2022 | ASTORG | OPEN HEALTH | UNITED STATES | Healthcare Services |
| 11/2020 | KERSIA | SOPURA | BELGIUM | Sterilization & Hygiene |
| 10/2020 | IK PARTNERS | KERSIA | FRANCE | Sterilization & Hygiene |
| 05/2020 | CLAYTON, DUBILIER & RICE (CD&R) | HUNTSWORTH | UNITED KINGDOM | Healthcare Services |
| 01/2018 | SPECTRIS | CONCEPT LIFE SCIENCES | UNITED KINGDOM | CRO / Clinical Trials |
| 04/2016 | CHARLES RIVER LABORATORIES | WIL RESEARCH | UNITED STATES | CRO / Clinical Trials |
| 04/2015 | CLINIGEN GROUP | IDIS | UNITED KINGDOM | Healthcare Services |
REFERENCES
Revenue range: REV £5–25M
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of Agentis Health Group by LDC are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Target: agentis health group
FAQ
What transaction does this page cover?
What was Agentis Health Group’s revenue at the time of the deal?
What sources support the information on this transaction?
What is mynth?